Insights on Fabry Disease Diagnosis and Genetic Testing

Understanding Fabry Disease Diagnosis

Diagnosis generally begins with an assessment of symptoms and family history. Healthcare professionals may consider Fabry disease when a person has unexplained findings that could involve several organ systems or when there is a known family history of the condition.

Laboratory testing can provide important evidence. Measurement of alpha galactosidase A enzyme activity is commonly used, particularly when evaluating males. However, enzyme activity may not reliably identify every affected female because enzyme levels can fall within a normal range in some females. Genetic testing is therefore particularly important when Fabry disease is suspected.

Diagnostic evaluation may include:

• Enzyme activity testing: Measures the activity of alpha galactosidase A in blood or other biological samples.
• GLA gene testing: Looks for disease causing genetic variants associated with Fabry disease.
• Clinical evaluation: Reviews symptoms, medical history, and possible involvement of organs such as the kidneys and heart.
• Family history assessment: Identifies relatives who may have inherited the same genetic variant.
• Additional laboratory tests: Kidney, heart, or other organ assessments may help determine whether the disease has affected specific organs.

In some situations, additional biochemical testing, such as measurement of globotriaosylsphingosine or related biomarkers, may support the diagnostic evaluation.

Role of Genetic Testing in Fabry Disease

Genetic testing can play an important role in confirming Fabry disease, particularly when enzyme testing is inconclusive. The test examines the GLA gene for variants that may interfere with alpha galactosidase A function. Identification of a disease causing variant can help establish the genetic basis of the condition.

Genetic testing can also have implications for relatives because Fabry disease follows an X linked inheritance pattern. A person with a confirmed disease causing variant may have relatives who could benefit from genetic evaluation.

Important considerations include:

• Variant interpretation: Not every genetic change found in the GLA gene necessarily causes Fabry disease. Specialists may need to determine whether a variant is disease causing.
• Testing relatives: Once a disease causing variant has been identified, targeted testing may be considered for potentially affected family members.
• Female diagnosis: Genetic testing is particularly valuable for females because enzyme activity testing alone may not detect all affected individuals.
• Genetic counseling: Counseling can help individuals understand test results, inheritance patterns, and potential implications for family members.
• Ongoing evaluation: A genetic diagnosis may be followed by assessments of kidney, cardiac, neurological, and other health concerns.

Genetic testing does not necessarily predict the exact symptoms or severity an individual will experience. Medical findings and clinical monitoring remain important components of evaluation.

Fabry disease diagnosis may require more than one type of test because symptoms and laboratory findings can vary. Enzyme activity testing, genetic analysis, clinical assessment, and family evaluation can work together to provide a clearer diagnostic picture. Genetic testing is particularly useful for confirming disease causing variants and identifying potentially affected relatives. Anyone concerned about Fabry disease should discuss symptoms, family history, and appropriate testing with a qualified healthcare professional or genetic counselor.